These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12463497)

  • 1. AZT myopathy and HIV-1 polymyositis: one disease or two?
    Walsh K; Kaye K; Demaerschalk B; Stewart S; Crukley J; Hammond R
    Can J Neurol Sci; 2002 Nov; 29(4):390-3. PubMed ID: 12463497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial myopathy caused by long-term zidovudine therapy.
    Dalakas MC; Illa I; Pezeshkpour GH; Laukaitis JP; Cohen B; Griffin JL
    N Engl J Med; 1990 Apr; 322(16):1098-105. PubMed ID: 2320079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zidovudine-induced experimental myopathy: dual mechanism of mitochondrial damage.
    Masini A; Scotti C; Calligaro A; Cazzalini O; Stivala LA; Bianchi L; Giovannini F; Ceccarelli D; Muscatello U; Tomasi A; Vannini V
    J Neurol Sci; 1999 Jul; 166(2):131-40. PubMed ID: 10475107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
    Grau JM; Masanés F; Pedrol E; Casademont J; Fernández-Solá J; Urbano-Márquez A
    Ann Neurol; 1993 Aug; 34(2):206-11. PubMed ID: 8338345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, histological and molecular reversibility of zidovudine myopathy.
    Masanés F; Barrientos A; Cebrián M; Pedrol E; Miró O; Casademont J; Grau JM
    J Neurol Sci; 1998 Aug; 159(2):226-8. PubMed ID: 9741412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Muscular involvement in the course of AIDS. Anatomo-clinical study of 17 cases].
    Butori C; Desnuelle C; Hofman P; Paquis V; Durant J; Carles M; Pesce A; Michiels JF
    Ann Pathol; 1995; 15(6):424-30. PubMed ID: 8720838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage.
    Dalakas MC; Leon-Monzon ME; Bernardini I; Gahl WA; Jay CA
    Ann Neurol; 1994 Apr; 35(4):482-7. PubMed ID: 8154877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine expression in the muscle of HIV-infected patients: evidence for interleukin-1 alpha accumulation in mitochondria of AZT fibers.
    Gherardi RK; Florea-Strat A; Fromont G; Poron F; Sabourin JC; Authier J
    Ann Neurol; 1994 Nov; 36(5):752-8. PubMed ID: 7979221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?
    Simpson DM; Citak KA; Godfrey E; Godbold J; Wolfe DE
    Neurology; 1993 May; 43(5):971-6. PubMed ID: 8492955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle studies in patients with HIV-related wasting syndrome.
    Miró O; Pedrol E; Cebrián M; Masanés F; Casademont J; Mallolas J; Grau JM
    J Neurol Sci; 1997 Sep; 150(2):153-9. PubMed ID: 9268244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions.
    Lane RJ; McLean KA; Moss J; Woodrow DF
    Neuropathol Appl Neurobiol; 1993 Oct; 19(5):406-13. PubMed ID: 8278024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy.
    Chariot P; Monnet I; Gherardi R
    Ann Neurol; 1993 Oct; 34(4):561-5. PubMed ID: 8215243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial myopathy associated with chronic zidovudine therapy in AIDS.
    Peters BS; Winer J; Landon DN; Stotter A; Pinching AJ
    Q J Med; 1993 Jan; 86(1):5-15. PubMed ID: 8438050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV or zidovudine myopathy?
    Grau JM; Casademont J
    Neurology; 1994 Feb; 44(2):361; author reply 362-4. PubMed ID: 8309595
    [No Abstract]   [Full Text] [Related]  

  • 15. HIV or zidovudine myopathy?
    Gherardi R; Chariot P
    Neurology; 1994 Feb; 44(2):361-2; author reply 362-4. PubMed ID: 8309597
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognosis in AZT myopathy.
    Chalmers AC; Greco CM; Miller RG
    Neurology; 1991 Aug; 41(8):1181-4. PubMed ID: 1714057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyositis in African HIV-infected subjects.
    Heckmann JM; Pillay K; Hearn AP; Kenyon C
    Neuromuscul Disord; 2010 Nov; 20(11):735-9. PubMed ID: 20630756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac dysfunction occurs in the HIV-1 transgenic mouse treated with zidovudine.
    Lewis W; Grupp IL; Grupp G; Hoit B; Morris R; Samarel AM; Bruggeman L; Klotman P
    Lab Invest; 2000 Feb; 80(2):187-97. PubMed ID: 10701688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome.
    Johnson RW; Williams FM; Kazi S; Dimachkie MM; Reveille JD
    Arthritis Rheum; 2003 Apr; 49(2):172-8. PubMed ID: 12687507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AZT-induced mitochondrial myopathy.
    Tomelleri G; Tonin P; Spadaro M; Tilia G; Orrico D; Barelli A; Bonetti B; Monaco S; Salviati A; Morocutti C
    Ital J Neurol Sci; 1992 Dec; 13(9):723-8. PubMed ID: 1336487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.